       Document 0212
 DOCN  M9610212
 TI    Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency
       syndrome.
 DT    9601
 AU    Winstanley P; Department of Pharmacology and Therapeutics, University
       of; Liverpool, UK.
 SO    Postgrad Med J. 1995 Jul;71(837):404-8. Unique Identifier : AIDSLINE
       MED/96004910
 AB    Toxoplasma gondii is a ubiquitous parasite, which causes several serious
       diseases. Until the AIDS pandemic, toxoplasmic encephalitis was largely
       confined to the pharmacologically immune-suppressed and to cases of
       congenital transmission. T gondii is now one of the more commonly
       encountered opportunistic pathogens of advanced AIDS.
 DE    Antimalarials/ADVERSE EFFECTS/PHARMACOKINETICS/*THERAPEUTIC USE
       AIDS-Related Opportunistic Infections/DIAGNOSIS/*DRUG THERAPY
       Clindamycin/ADVERSE EFFECTS/PHARMACOKINETICS/*THERAPEUTIC USE  Human
       Naphthoquinones/PHARMACOLOGY  Pyrimethamine/ADVERSE
       EFFECTS/PHARMACOKINETICS/*THERAPEUTIC USE  Sulfadiazine/ADVERSE
       EFFECTS/PHARMACOKINETICS/*THERAPEUTIC USE  Toxoplasmosis,
       Cerebral/DIAGNOSIS/*DRUG THERAPY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

